table of content
1 Study Coverage
1.1 Sustained Release Ocular Drug Delivery Systems Product Introduction
1.2 Global Sustained Release Ocular Drug Delivery Systems Outlook 2017 VS 2022 VS 2028
1.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales in US$ Million for the Year 2017-2028
1.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume for the Year 2017-2028
1.3 United States Sustained Release Ocular Drug Delivery Systems Outlook 2017 VS 2022 VS 2028
1.3.1 United States Sustained Release Ocular Drug Delivery Systems Sales in US$ Million for the Year 2017-2028
1.3.2 United States Sustained Release Ocular Drug Delivery Systems Sales in Volume for the Year 2017-2028
1.4 Sustained Release Ocular Drug Delivery Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Sustained Release Ocular Drug Delivery Systems in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Sustained Release Ocular Drug Delivery Systems Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Sustained Release Ocular Drug Delivery Systems Market Dynamics
1.5.1 Sustained Release Ocular Drug Delivery Systems Industry Trends
1.5.2 Sustained Release Ocular Drug Delivery Systems Market Drivers
1.5.3 Sustained Release Ocular Drug Delivery Systems Market Challenges
1.5.4 Sustained Release Ocular Drug Delivery Systems Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Sustained Release Ocular Drug Delivery Systems Market Segment by Type
2.1.1 Liposome
2.1.2 Microcapsules/Nanocapsules
2.1.3 Microspheres/Nanosptheres
2.1.4 Implants
2.2 Global Sustained Release Ocular Drug Delivery Systems Market Size by Type
2.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Sustained Release Ocular Drug Delivery Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Sustained Release Ocular Drug Delivery Systems Market Size by Type
2.3.1 United States Sustained Release Ocular Drug Delivery Systems Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Sustained Release Ocular Drug Delivery Systems Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Sustained Release Ocular Drug Delivery Systems Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Sustained Release Ocular Drug Delivery Systems Market Segment by Application
3.1.1 Cataract
3.1.2 Glaucoma
3.1.3 Corneal Transplantation
3.1.4 Others
3.2 Global Sustained Release Ocular Drug Delivery Systems Market Size by Application
3.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Sustained Release Ocular Drug Delivery Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Sustained Release Ocular Drug Delivery Systems Market Size by Application
3.3.1 United States Sustained Release Ocular Drug Delivery Systems Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Sustained Release Ocular Drug Delivery Systems Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Sustained Release Ocular Drug Delivery Systems Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Sustained Release Ocular Drug Delivery Systems Competitor Landscape by Company
4.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Company
4.1.1 Top Global Sustained Release Ocular Drug Delivery Systems Manufacturers Ranked by Revenue (2021)
4.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue by Manufacturer (2017-2022)
4.1.3 Global Sustained Release Ocular Drug Delivery Systems Sales by Manufacturer (2017-2022)
4.1.4 Global Sustained Release Ocular Drug Delivery Systems Price by Manufacturer (2017-2022)
4.2 Global Sustained Release Ocular Drug Delivery Systems Concentration Ratio (CR)
4.2.1 Sustained Release Ocular Drug Delivery Systems Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Sustained Release Ocular Drug Delivery Systems in 2021
4.2.3 Global Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Sustained Release Ocular Drug Delivery Systems Manufacturing Base Distribution, Product Type
4.3.1 Global Sustained Release Ocular Drug Delivery Systems Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
4.3.3 Date of International Manufacturers Enter into Sustained Release Ocular Drug Delivery Systems Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Sustained Release Ocular Drug Delivery Systems Market Size by Company
4.5.1 Top Sustained Release Ocular Drug Delivery Systems Players in United States, Ranked by Revenue (2021)
4.5.2 United States Sustained Release Ocular Drug Delivery Systems Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Sustained Release Ocular Drug Delivery Systems Sales by Players (2020, 2021 & 2022)
5 Global Sustained Release Ocular Drug Delivery Systems Market Size by Region
5.1 Global Sustained Release Ocular Drug Delivery Systems Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Sustained Release Ocular Drug Delivery Systems Market Size in Volume by Region (2017-2028)
5.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume by Region: 2017-2022
5.2.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Volume Forecast by Region (2023-2028)
5.3 Global Sustained Release Ocular Drug Delivery Systems Market Size in Value by Region (2017-2028)
5.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region: 2017-2022
5.3.2 Global Sustained Release Ocular Drug Delivery Systems Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Sustained Release Ocular Drug Delivery Systems Market Size YoY Growth 2017-2028
6.1.2 North America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Sustained Release Ocular Drug Delivery Systems Market Size YoY Growth 2017-2028
6.3.2 Europe Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Sustained Release Ocular Drug Delivery Systems Market Size YoY Growth 2017-2028
6.4.2 Latin America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 pSivida
7.1.1 pSivida Corporation Information
7.1.2 pSivida Description and Business Overview
7.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.1.4 pSivida Sustained Release Ocular Drug Delivery Systems Products Offered
7.1.5 pSivida Recent Development
7.2 Allergan
7.2.1 Allergan Corporation Information
7.2.2 Allergan Description and Business Overview
7.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Allergan Sustained Release Ocular Drug Delivery Systems Products Offered
7.2.5 Allergan Recent Development
7.3 Icon Bioscience
7.3.1 Icon Bioscience Corporation Information
7.3.2 Icon Bioscience Description and Business Overview
7.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Products Offered
7.3.5 Icon Bioscience Recent Development
7.4 Ocular Therapeutix
7.4.1 Ocular Therapeutix Corporation Information
7.4.2 Ocular Therapeutix Description and Business Overview
7.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Products Offered
7.4.5 Ocular Therapeutix Recent Development
7.5 Neurotech Pharmaceuticals
7.5.1 Neurotech Pharmaceuticals Corporation Information
7.5.2 Neurotech Pharmaceuticals Description and Business Overview
7.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
7.5.5 Neurotech Pharmaceuticals Recent Development
7.6 Santen Pharmaceutical
7.6.1 Santen Pharmaceutical Corporation Information
7.6.2 Santen Pharmaceutical Description and Business Overview
7.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Products Offered
7.6.5 Santen Pharmaceutical Recent Development
7.7 Aciont Inc.
7.7.1 Aciont Inc. Corporation Information
7.7.2 Aciont Inc. Description and Business Overview
7.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Products Offered
7.7.5 Aciont Inc. Recent Development
7.8 Envisia Therapeutics
7.8.1 Envisia Therapeutics Corporation Information
7.8.2 Envisia Therapeutics Description and Business Overview
7.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Products Offered
7.8.5 Envisia Therapeutics Recent Development
7.9 GrayBug
7.9.1 GrayBug Corporation Information
7.9.2 GrayBug Description and Business Overview
7.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.9.4 GrayBug Sustained Release Ocular Drug Delivery Systems Products Offered
7.9.5 GrayBug Recent Development
7.10 Innocore Pharmaceuticals
7.10.1 Innocore Pharmaceuticals Corporation Information
7.10.2 Innocore Pharmaceuticals Description and Business Overview
7.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
7.10.5 Innocore Pharmaceuticals Recent Development
7.11 OHR Pharmaceuticals
7.11.1 OHR Pharmaceuticals Corporation Information
7.11.2 OHR Pharmaceuticals Description and Business Overview
7.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.11.4 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Products Offered
7.11.5 OHR Pharmaceuticals Recent Development
7.12 PolyActiva
7.12.1 PolyActiva Corporation Information
7.12.2 PolyActiva Description and Business Overview
7.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.12.4 PolyActiva Products Offered
7.12.5 PolyActiva Recent Development
7.13 TheraKine
7.13.1 TheraKine Corporation Information
7.13.2 TheraKine Description and Business Overview
7.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
7.13.4 TheraKine Products Offered
7.13.5 TheraKine Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Sustained Release Ocular Drug Delivery Systems Industry Chain Analysis
8.2 Sustained Release Ocular Drug Delivery Systems Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Sustained Release Ocular Drug Delivery Systems Distributors
8.3 Sustained Release Ocular Drug Delivery Systems Production Mode & Process
8.4 Sustained Release Ocular Drug Delivery Systems Sales and Marketing
8.4.1 Sustained Release Ocular Drug Delivery Systems Sales Channels
8.4.2 Sustained Release Ocular Drug Delivery Systems Distributors
8.5 Sustained Release Ocular Drug Delivery Systems Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
